Notable differences were observed through the assessment of primary and metastatic samples of seminoma, revealing BRD4 mutations were overrepresented in metastatic cases (p = 0.00125), while KIT mutations were more common in primary samples (p = 0.00191). Here, BRD4 is linked to seminoma.